Jianping Dou
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Surgery 12
- Thyroid and Parathyroid Surgery 4
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Jie Yu (43 shared papers)Ping Liang (44 shared papers)Xianwei Meng (6 shared papers)Xiaoling Yu (23 shared papers)Longfei Tan (5 shared papers)Fangyi Liu (27 shared papers)Zhigang Cheng (23 shared papers)Zhiyu Han (23 shared papers)
- Journals
- International Journal of Hyperthermia (9 papers)Ultrasound in Medicine & Biology (4 papers)Abdominal Radiology (3 papers)ACS Nano (3 papers)European Radiology (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Jianping Dou
58 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 100
- Hepatology 196
- Biomaterials 207
- Nephrology 89
- Biomedical Engineering 435
- Endocrinology, Diabetes and Metabolism 95
Countries citing papers authored by Jianping Dou
This map shows the geographic impact of Jianping Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Dou more than expected).
Fields of papers citing papers by Jianping Dou
This network shows the impact of papers produced by Jianping Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Dou. The network helps show where Jianping Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 108 | |
| 2 | 2016 | 103 | |
| 3 | 2013 | 90 | |
| 4 | 2019 | 84 | |
| 5 | 2021 | 81 | |
| 6 | 2020 | 68 | |
| 7 | 2016 | 54 | |
| 8 | 2022 | 49 | |
| 9 | 2023 | 47 | |
| 10 | 2019 | 42 | |
| 11 | 2016 | 39 | |
| 12 | 2022 | 29 | |
| 13 | 2017 | 28 | |
| 14 | 2020 | 27 | |
| 15 | 2018 | 24 | |
| 16 | 2023 | 23 | |
| 17 | 2019 | 23 | |
| 18 | 2019 | 22 | |
| 19 | 2021 | 22 | |
| 20 | 2021 | 20 |
About Jianping Dou
Jianping Dou is a scholar working on Hepatology, Surgery, Biomedical Engineering, Endocrinology, Diabetes and Metabolism and Biomaterials, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Nanoplatforms for cancer theranostics (9 papers), Thyroid Cancer Diagnosis and Treatment (8 papers), Nanoparticle-Based Drug Delivery (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Thyroid and Parathyroid Surgery (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Hepatology (196 citations), Biomaterials (207 citations), Nephrology (89 citations), Biomedical Engineering (435 citations) and Endocrinology, Diabetes and Metabolism (95 citations). Jianping Dou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jie Yu, Ping Liang, Xianwei Meng, Xiaoling Yu, Longfei Tan, Fangyi Liu, Zhigang Cheng, Zhiyu Han, Tianlong Liu and Changhui Fu. Their work appears in journals such as International Journal of Hyperthermia, Ultrasound in Medicine & Biology, Abdominal Radiology, ACS Nano and European Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.